✦ LIBER ✦

Use of extracorporeal albumin dialysis for erythropoietic protoporphyria

✍ Scribed by Brendan M. McGuire; Joseph R. Bloomer

Book ID: 102467117
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 124 KB
Volume: 13
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pretransplant albumin dialysis in erythr

Pretransplant albumin dialysis in erythropoietic protoporphyria: A costly detour

✍ Staffan Wahlin; Pauline Harper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

UK experience of liver transplantation f

UK experience of liver transplantation for erythropoietic protoporphyria

✍ Joanna K. Dowman; Briget K. Gunson; Darius F. Mirza; Mike N. Badminton; Philip N 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 174 KB

Screening for ferrochelatase mutations:

Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria

✍ Wang, Xiuhua; Poh-Fitzpatrick, Maureen; Taketani, Shigeru; Chen, Timothy; Piomel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Increase of Octanoate Concentrations Dur

Increase of Octanoate Concentrations During Extracorporeal Albumin Dialysis Treatments

✍ Sebastian Klammt; Sebastian Koball; Heiko Hickstein; Martin Gloger; Joerg Hensch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Pharmacokinetics of Liposomal Amphoteric

Pharmacokinetics of Liposomal Amphotericin B During Extracorporeal Albumin Dialysis

✍ Helene Vogelsinger; Michael Joannidis; Jordan Kountchev; Rosa Bellmann-Weiler; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Randomized controlled study of extracorp

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis

✍ Tarek I. Hassanein; Flemming Tofteng; Robert S. Brown Jr.; Brendan McGuire; Patr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

Extracorporeal albumin dialysis (ECAD) may improve severe hepatic encephalopathy (HE) in patients with advanced cirrhosis via the removal of protein or non-protein-bound toxins. A prospective, randomized, controlled, multicenter trial of the efficacy, safety, and tolerability of ECAD using molecular